TAK-085
TAK-085-4002
Approved small_molecule completed
Quick answer
TAK-085 for Hyperlipidemia is a Approved program (small_molecule) at Takeda with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Hyperlipidemia
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed